The Real Cost of MLR

Imagine your most senior medical director spent a quarter of their week away from their primary job, and instead reviewing content and materials. 

Now imagine that’s happening across all medical directors at your company, and across the industry.

And now, don’t imagine anything, because this is already happening. It’s not just inefficient – it’s costing pharma millions in wasted time.

We can do better. In this webinar, we’ll unveil new data that shows just how much effort and commitment your teams require. With 44% of companies still relying on their top medical directors to review promotional content – sometimes without formal training – it’s clear that the system is broken. These are leaders hired for their strategic vision, not for navigating the details of review.

It gets worse. The increased volume of digital content and the growing complexity of scientific communication are putting unprecedented strain on an already overburdened process. As medical affairs teams stretch their resources thin, the risk of errors, delays, and burnout only increases.

Join us as we detail the scale of the problem, and explore practical solutions. You’ll hear from experts who have navigated these pitfalls and found ways to centralize, optimize, digitize and externalize the MLR process. We’ll discuss the benefits of dedicated MLR roles and outsourcing to ensure better HCP relationships, a smoother path to market and of course, better patient outcomes.